A change in one is not a change in the others
The dominant drug segment benefits from extensive clinical validation and proven therapeutic outcomes across diabetes, obesity, and cardiovascular applications
In a study comparing the effects of semaglutide and tirzepatide for weight loss, those receiving tirzepatide were more likely to achieve 5% or greater, 10% or greater, and 15% or greater weight loss and experienced larger reductions in body weight at 3, 6, and 12 months
Sulfur burps can be an unpleasant but often temporary side effect of GLP-1 medications
10.1124/dmd.31.8.1035 Drug Metab
Previously used for various conditions in dermatology, some expanded its use to skin whitening treatments